Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
VeerHealth Care plans expansion, to invest Rs 33 crores
This investment encompasses various aspects including the acquisition of land, construction of buildings, procurement of plant and…
Takeda oncology pipeline remains robust despite shift in focus from CAR-T to allogeneic cell…
Takeda entered into multiple cell therapy collaborations for the development of CAR-T therapies with organizations like Memorial…
Decoding the skirmish over revised Schedule M
Both, large and mid/small size pharma companies, are vital parts of India’s pharma sector, one serving export markets, the other…
Daiichi Sankyo poised to add another ADC blockbuster with datopotamab deruxtecan for non-squamous…
GlobalData estimates the drug to earn $3.12 billion by 2029
India pharma giants and global big pharma join forces for NMEs commercialisation in India:…
The focus is on introducing new molecular entities (NMEs) into India, with both parties contributing to accelerate…
Top 20 global biopharma companies report 1.6 per cent per cent market cap growth to $3.67 tn in…
Four companies – Lilly (59.2 per cent), Novo Nordisk (51.5 per cent), Vertex Pharmaceuticals (41.4 per cent) and Regeneron…
Alkaloid has developed ready-to-use liquid Omeprazole
This drug is primarily designed to treat reflux esophagitis and GERD in young children unable to swallow tablets, as well as in…
Viatris gets global Minimised Risk of AMR Certification
Aurangabad, India site is the country’s first pharma facility, and first in Viatris’ network, to meet new British Standards…
Biocon included in S&P Global Sustainability Yearbook 2024
S&P Global ESG Score at 63; inducted in Dow Jones Sustainability Emerging Markets Index for third year in a row
Alirocumab can address unmet needs in pediatric familial hypercholesterolemia: GlobalData
Praluent (alirocumab) is a monoclonal antibody against proprotein convertase subtilisin kexin type 9 (PCSK9), an enzyme that…